FIELD: medicine.
SUBSTANCE: invention provides a method of preventing or treating bacterial infections in pulmonary system. Method involves inhalation of an aerosolised dose of 150-250 mg/ml aqueous solution of tobramycin, where administration is performed using dispensing inhaler, providing formation of aerosol with mass median aerodynamic diameter of 4-7 mcm, where dispensing inhaler has a spraying nozzle providing formation of said aerosols by transfer of composition through holes with diameter of 1.8-3.9 mcm. Average maximum concentration in plasma is lower in comparison with level of equipment, which is an additional advantage since tobramycin in plasma causes undesirable side effects.
EFFECT: fast and efficient administration of tobramycin, improved dosing regimen.
17 cl, 8 dwg, 19 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING ENDOBRONCHIAL DISEASES | 2005 |
|
RU2389477C2 |
| COMBINED PREPARATIONS OF AMINOGLYCOSIDES AND PHOSPHOMYCIN, HAVING IMPROVED CHEMICAL PROPERTIES | 2014 |
|
RU2691658C2 |
| LIQUID PREPARATION CONTAINING TOBRAMYCINE | 2004 |
|
RU2341267C2 |
| AQUEOUS COMPOSITIONS CONTAINING ARBEKACINE | 2012 |
|
RU2604767C2 |
| INTRODUCTION OF ILOPROST IN FORM OF AEROSOL BOLUSES | 2012 |
|
RU2605849C2 |
| RAPAMYCIN FOR TREATING LYMPHANGIOLEIOMYOMATOSIS | 2014 |
|
RU2707285C2 |
| INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
| MICROPARTICLES WITH ANTIBIOTIC FOR INHALATION | 2010 |
|
RU2555772C2 |
| METHOD OF TREATING PULMONARY DISEASES WITH LIPOSOMAL AMIKACIN FORMULATIONS | 2009 |
|
RU2537238C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE | 2006 |
|
RU2421209C2 |
